Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Lower-Risk Myelodysplastic Syndromes

Acceleron Pharma 12.11.2015

Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Beta-Thalassemia Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition

Acceleron Pharma 12.11.2015

Acceleron Pharma Reports Third Quarter 2015 Financial and Operational Results

Acceleron Pharma 11.04.2015

Acceleron Highlights Phase 3 Studies, New Clinical Results and Research Strategies at Research and Development Day Event

Acceleron Pharma 10.23.2015

Acceleron Presents Preclinical Data for ACE-083 and ACE-2494 at the 20th International Annual Congress of the World Muscle Society

Acceleron Pharma 10.01.2015

Acceleron Pharma Reports Second Quarter 2015 Financial and Operational Results

Acceleron Pharma 08.06.2015

Acceleron Announces Publication in Cancer Research Demonstrating Dalantercept Prevents Metastases in Preclinical Studies of Breast Cancer

Acceleron Pharma 06.15.2015

Acceleron Announces New Luspatercept Phase 2 Clinical Results at the 20th Congress of the European Hematology Association

Acceleron Pharma 06.12.2015

Loading